Table 2.
Detectability of TDMs in BWF_Sup and BWF_Pre in patients with or without BWF atypical cells.
| BWF_Sup | ||||||||
|---|---|---|---|---|---|---|---|---|
| Total | Driver | |||||||
| + | − | P value | + | − | P value | |||
| BWF_pre | All patients (n = 63)* | + | 321 | 14 | <0.001 | 110 | 2 | 0.036 |
| − | 63 | 70 | 14 | 11 | ||||
| Atypical cells (+) (n = 39) | + | 199 | 12 | 0.347 | 74 | 1 | 1.000 | |
| − | 21 | 37 | 1 | 5 | ||||
| Atypical cells (–) (n = 24) | + | 122 | 2 | <0.001 | 36 | 1 | 0.007 | |
| − | 42 | 33 | 13 | 6 | ||||
*Only include patients whose FFPE was successfully detected with somatic SNVs, Indels or SVs.